Adrià Nicolàs-Aragó

Mr. Adrià Nicolàs-Aragó

IRB Barcelona
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Joana FortJoana Fort
Joana Fort
Adrià Nicolàs-AragóAdrià Nicolàs-Aragó
Adrià Nicolàs-Aragó
MPManuel Palacín
Manuel Palacín
It is known that 4F2hc and rBAT are the heavy subunits of the heteromeric amino acid transporters (HATs). These heavy subunits are N-glycosylated proteins, with an N-terminal domain, one transmembrane domain and a bulky extracellular domain (ectodomain) that belongs to the α-amylase family. The heavy subunits are covalently linked to a light subunit from the SLC7 family, which is responsible for the amino acid transport activity, forming a heterodimer. The functions of 4F2hc and rBAT are related mainly to the stability and trafficking of the HATs in the plasma membrane of vertebrates, where they exert the transport activity. Moreover, 4F2hc is a modulator of integrin signaling, has a role in cell fusion and it is overexpressed in some types of cancers. On the other hand, some mutations in rBAT are found to cause the malfunctioning of the b0,+ transport system, leading to cystinuria. The ectodomains of 4F2hc and rBAT share both sequence and structure homology with α-amylase family members. Very recently, cryo-EM has revealed the structure of several HATs, including the ectodomains of rBAT and 4F2hc. Here, we analyze available data on the ectodomains of rBAT and 4Fhc and their relationship with the α-amylase family. The physiological relevance of this relationship remains largely unknown.

8 August 2021 in Membranes
Verified
Journal Article
Open access
PDF file
Adrià Nicolàs-AragóAdrià Nicolàs-Aragó
Adrià Nicolàs-Aragó
Joana FortJoana Fort
Joana Fort
MPManuel Palacín
Manuel Palacín
Ekaitz Errasti-MurugarrenEkaitz Errasti-Murugarren
Ekaitz Errasti-Murugarren
The mammalian SLC7 family comprises the L-amino acid transporters (LATs) and the cationic amino acid transporters (CATs). The relevance of these transporters is highlighted by their involvement in several human pathologies, including inherited rare diseases and acquired diseases, such as cancer. In the last four years, several crystal or cryo-EM structures of LATs and CATs have been solved. These structures have started to fill our knowledge gap that previously was based on the structural biology of remote homologs of the amino acid–polyamine–organocation (APC) transporters. This review recovers this structural and functional information to start generating the molecular bases of the transport cycle of LATs. Special attention is given to the known transporter conformations within the transport cycle and the molecular bases for substrate interaction and translocation, including the asymmetric interaction of substrates at both sides of the plasma membrane.

23 December 2024 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
Joana FortJoana Fort
Joana Fort
Adrià Nicolàs-AragóAdrià Nicolàs-Aragó
Adrià Nicolàs-Aragó
LMLuca Maggi
Luca Maggi
MMMaria Martinez-Molledo
Maria Martinez-Molledo
DKDespoina Kapiki
Despoina Kapiki
MPManuel Palacín
Manuel Palacín
L-Amino acid transporters (LATs) play a key role in a wide range of physiological processes. Defects in LATs can lead to neurological disorders and aminoacidurias, while the overexpression of these transporters is related to cancer. BasC is a bacterial LAT transporter with an APC fold. In this study, to monitor the cytoplasmic motion of BasC, we developed a single-molecule Förster resonance energy transfer assay that can characterize the conformational states of the intracellular gate in solution at room temperature. Based on combined biochemical and biophysical data and molecular dynamics simulations, we propose a model in which the conserved lysine residue in TM5 supports TM1a to explore both open and closed states within the cytoplasmic gate under apo conditions. This equilibrium can be altered by substrates, mutation of conserved lysine 154 in TM5, or a transport-blocking nanobody interacting with TM1a. Overall, these findings provide insights into the transport mechanism of BasC and highlight the significance of the lysine residue in TM5 in the cytoplasmic gating of LATs.

13 November 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
Adrià Nicolàs-AragóAdrià Nicolàs-Aragó
Adrià Nicolàs-Aragó
DDDaniel Zocchi Doherty
Daniel Zocchi Doherty
PGPatricia Gómez-Gejo
Patricia Gómez-Gejo
PBPaola Bartoccioni
Paola Bartoccioni
EPEls Pardon
Els Pardon
Joana FortJoana Fort
Joana Fort
Nanobodies are valuable tools for stabilizing and investigating membrane transporters, but the systematic characterization of large nanobody collections remains experimentally demanding. Here, we combined biochemical and transport assays, experimental structural data and AlphaFold3 modelling to characterize a repertoire of 29 nanobodies targeting the bacterial amino acid transporter BasC. By exploiting the random orientation and asymmetric apparent substrate affinities of BasC in proteoliposomes, comparison of nanobody-mediated influx and efflux inhibition enabled experimental assignment of binding sidedness. The collection showed a marked bias towards inhibition from the intracellular face, whereas only two, Nb58 and Nb78, were identified as extracellular binders. Compatibility assays and a 6.1 Å crystallographic map of the BasC–Nb53–Nb58 complex supported the simultaneous binding of Nb53 and Nb58 to opposite sides of the transporter and validated the functional sidedness assignment. AlphaFold3 generated high-confidence interaction models for 16 of the 29 complexes. Ten of these models targeted the large intracellular cavity, revealing recurrent epitope clusters. The predicted binding modes of Nb53, Nb71 and Nb74 agreed with available experimental structures, supporting the accuracy of these predictions. Notably, these three nanobodies had previously provided the most informative structural and smFRET data. Our results show that transport-based sidedness measurements together with confidence-filtered structural predictions can define the functional and structural landscape of a nanobody repertoire. This integrated approach may provide a virtual structural screening strategy to prioritize nanobodies, identify dominant epitope regions and select potentially compatible combinations for experimental and structural studies.